Trials / Recruiting
RecruitingNCT07069673
Abbott Cephea Mitral Valve Disease Registry
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this registry is to gather clinical data on symptomatic patients with mitral valve disease, including patients with mitral regurgitation, mitral stenosis, and mixed mitral valve disease. Data collected from this registry are expected to improve our understanding of the impact of correcting symptomatic mitral valve disease on clinical outcomes in patients that could be candidates for Transcatheter Mitral Valve Replacement and may also inform future regulatory or reimbursement submission strategies for the Cephea Mitral Valve System.
Conditions
- Mitral Regurgitation
- Mitral Stenosis
- Mitral Valve Disease
- Mitral Valve (MV) Regurgitation
- Mitral Annulus Calcification
- Mitral Valve Replacement
- Transcatheter Valve Replacement
Timeline
- Start date
- 2025-08-13
- Primary completion
- 2028-12-01
- Completion
- 2028-12-01
- First posted
- 2025-07-17
- Last updated
- 2026-03-11
Locations
19 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT07069673. Inclusion in this directory is not an endorsement.